Cost-Effectiveness of Alirocumab Based on Evidence From a Large Multinational Outcome Trial: The ODYSSEY OUTCOMES Economics Study
Publication
, Conference
Bhatt, DL; Briggs, A; Reed, SD; Annemans, L; Szarek, M; Bittner, VA; Diaz, R; Edelberg, JM; Goodman, SG; Hanotin, C; Harrington, RA; Pordy, R ...
Published in: CIRCULATION
December 18, 2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E753 / E754
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bhatt, D. L., Briggs, A., Reed, S. D., Annemans, L., Szarek, M., Bittner, V. A., … Steg, G. (2018). Cost-Effectiveness of Alirocumab Based on Evidence From a Large Multinational Outcome Trial: The ODYSSEY OUTCOMES Economics Study. In CIRCULATION (Vol. 138, pp. E753–E754). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Bhatt, Deepak L., Andrew Briggs, Shelby D. Reed, Lieven Annemans, Michael Szarek, Vera A. Bittner, Rafael Diaz, et al. “Cost-Effectiveness of Alirocumab Based on Evidence From a Large Multinational Outcome Trial: The ODYSSEY OUTCOMES Economics Study.” In CIRCULATION, 138:E753–54. LIPPINCOTT WILLIAMS & WILKINS, 2018.
Bhatt DL, Briggs A, Reed SD, Annemans L, Szarek M, Bittner VA, et al. Cost-Effectiveness of Alirocumab Based on Evidence From a Large Multinational Outcome Trial: The ODYSSEY OUTCOMES Economics Study. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E753–4.
Bhatt, Deepak L., et al. “Cost-Effectiveness of Alirocumab Based on Evidence From a Large Multinational Outcome Trial: The ODYSSEY OUTCOMES Economics Study.” CIRCULATION, vol. 138, no. 25, LIPPINCOTT WILLIAMS & WILKINS, 2018, pp. E753–54.
Bhatt DL, Briggs A, Reed SD, Annemans L, Szarek M, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Sanchez R, Higuchi K, White HD, Zeiher AM, Schwartz GG, Steg G. Cost-Effectiveness of Alirocumab Based on Evidence From a Large Multinational Outcome Trial: The ODYSSEY OUTCOMES Economics Study. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E753–E754.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E753 / E754
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology